| REVERAGEN BIOPHARMA ReveraGen Biopharma, Inc.
86386224 05 Sep 2014 | on 09 Aug 2021
| Pharmaceutical research and development Class 042 Class 042 Computer & Software Services & Scientific Services Pharmaceutical research and development | | | REVERAGEN ReveraGen Biopharma, Inc.
86386229 05 Sep 2014 | on 09 Aug 2021
| Pharmaceutical research and development Class 042 Class 042 Computer & Software Services & Scientific Services Pharmaceutical research and development | | | REVERA GEN Reveragen Biopharma, Inc
85466781 08 Nov 2011 | on 29 Aug 2014 | Therapeutic pharmaceutical for the treatment of neuromuscular disease,... Class 005 Class 005 Pharmaceutical Products The mark consists of the word "REVERA" in black with the "R" capitalized and the "V" in red with "GEN" below in black having a capital "G" and a stylized "N" and a grey incomplete elliptical line runs behind the words and through the "V" and there is a solid grey bead and a small open circle on the line. Class 042 Class 042 Computer & Software Services & Scientific Services Therapeutic pharmaceutical for the treatment of neuromuscular disease | | | REVERAGEN Reveragen BioPharma, Inc
85466817 08 Nov 2011 | on 29 Aug 2014 | Therapeutic pharmaceutical for the treatment of neuromuscular disease,... Class 005 Class 005 Pharmaceutical Products The mark consists of the word "REVERAGEN" in black letters with a red "V" and an initial capital letter "R" and a capital "G" and a stylized "N" for the final "N" Class 042 Class 042 Computer & Software Services & Scientific Services The mark consists of the word "REVERAGEN" in black letters with a red "V" and an initial capital letter "R" and a capital "G" and a stylized "N" for the final "N" | |